Skip to main content

Peer Review reports

From: Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types

Original Submission
28 Sep 2020 Submitted Original manuscript
22 Nov 2020 Author responded Author comments - Sojung Park
2 Nov 2020 Reviewed Reviewer Report
6 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 2
22 Nov 2020 Submitted Manuscript version 2
21 Dec 2020 Author responded Author comments - Sojung Park
14 Dec 2020 Reviewed Reviewer Report
18 Dec 2020 Reviewed Reviewer Report
Resubmission - Version 3
21 Dec 2020 Submitted Manuscript version 3
Publishing
23 Dec 2020 Editorially accepted
11 Jan 2021 Article published 10.1186/s12885-020-07765-6

You can find further information about peer review here.

Back to article page